Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
PT-141 is contraindicated in patients with uncontrolled hypertension
the caution applies particularly to inhaled or intravenous NAC, which may occasionally trigger bronchospasm
If a supplier cannot provide third-party testing results, consider that a major red flag regardless of how attractive the pricing looks
Succinate is an inflammatory signal that induces IL-1 through HIF-1
Analysts have cautioned that neither oral agent is likely to carry a significant price discount over time, given that the same manufacturers control both oral and injectable portfolios
US$ 20.18
US$ 20.51
US$ 27.88
US$ 24.51
US$ 25.27
